Otonomy Appoints Kathie M. Bishop, Ph.D., as Chief Scientific Officer

Back to Jobs

SAN DIEGO , Nov. 30, 2016 (GLOBE NEWSWIRE) — Otonomy , Inc. (NASDAQ:OTIC), a biopharmaceutical company focused on the development and commercialization of innovative therapeutics for diseases and disorders of the ear, today announced the appointment of Kathie M.

Apply Now